COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Overview of attention for article published in Thrombosis Journal, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 344)
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 20 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 26 X posts from 20 X users, with an upper bound of 30,571 followers.

RT @DanielReyAldana: COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thro…

17 Oct 2018

Reply Repost Favourite

COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text #MFyC #ACOD https://t.co/e3eE4tf1yu

15 Oct 2018

Reply Repost Favourite

RT @Thrombosis_J: COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thrombo…

13 Oct 2018

Reply Repost Favourite

RT @Thrombosis_J: COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thrombo…

13 Oct 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 22 additional X posts.